HUM - Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Humana Inc. (HUM) | Benzinga

LOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming August 2, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Humana Inc. ("Humana" or the "Company") (NYSE:HUM) common stock between July 27, 2022, and January 24, 2024, inclusive (the "Class Period").

If you suffered a loss on your Humana investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/Humana-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On June 13, 2023, one of Humana's primary competitors, UnitedHealth Group Inc. ("UnitedHealth") revealed that it was seeing "higher levels" of outpatient care activity due, potentially, to "pent-up demand or delayed demand being satisfied." On this news, Humana's stock price fell $57.63, or 11.2%, to close at $455.00 per share on June 14, 2023, thereby injuring investors.

Then, on June 16, 2023, Humana confirmed that it was also experiencing "higher than anticipated non-inpatient utilization trends, predominately in the categories of emergency room, outpatient surgeries, and dental services, as well as inpatient trends that ...

HUM)>Full story available on Benzinga.com